BlackRock’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Sell
419,640
-6,927
-2% -$28.9K ﹤0.01% 4161
2025
Q4
$1.84M Buy
426,567
+154,791
+57% +$590K ﹤0.01% 4139
2025
Q3
$1.18M Buy
271,776
+2,103
+0.8% +$9.48K ﹤0.01% 4244
2025
Q2
$1.25M Buy
+269,673
New +$1.07M ﹤0.01% 4185

Other funds holding SBC

BlackRock's SBC Position: Q1 2026 in Review

BlackRock reduced its SBC Medical Group (SBC) stake by 1.6% in Q1 2026, selling an estimated $28.9K and leaving 419,640 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #4161.

BlackRock first reported a position in SBC in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.84M in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • BlackRock held 419,640 shares of SBC Medical Group worth $1.75M as of Q1 2026.
  • BlackRock sold 6,927 SBC Medical Group shares in Q1 2026, an estimated $28.9K.
  • SBC Medical Group made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4161 holding.
  • BlackRock first reported a position in SBC Medical Group in Q2 2025 and has held it in 4 quarters since.
  • BlackRock's SBC Medical Group position peaked at $1.84M in Q4 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.